Targeting better control with biologic therapy. In the United States, asthma affects 8% of adults and 7% children1. Asthma is a chronic inflammatory respiratory disease characterized by reversible airway obstruction and hyper-responsiveness with symptoms of wheeze, shortness of breath, chest tightness and cough2. Despite optimization of standard care regimens, ... Continue Reading